Secondary Logo

Institutional members access full text with Ovid®

Clinical and Histological Evaluations of Enlarged Facial Skin Pores After Low Energy Level Treatments With Fractional Carbon Dioxide Laser in Korean Patients

Kwon, Hyuck Hoon, MD, PhD*; Choi, Sun Chul, MD*; Lee, Won-Yong, MD, MS; Jung, Jae Yoon, MD, MS*; Park, Gyeong-Hun, MD, PhD

doi: 10.1097/DSS.0000000000001313
Original Article

BACKGROUND Enlarged facial pores can be an early manifestation of skin aging and they are a common aesthetic concern for Asians. However, studies of improving the appearance of enlarged pores have been limited.

OBJECTIVE The authors aimed to study the application of CO2 fractional laser treatment in patients with enlarged facial pores.

METHODS A total of 32 patients with dilated facial pores completed 3 consecutive sessions of low energy level treatments with a fractional CO2 laser at 4-week intervals. Image analysis was performed to calculate the number of enlarged pores before each treatment session and 12 weeks after the final treatment.

RESULTS After application of laser treatments, there was a significant decrease in the number of enlarged pores. The mean number of enlarged pores was decreased by 28.8% after the second session and by 54.5% at post-treatment evaluation. Post-treatment side effects were mild and transitory. Histological and immunohistochemical analyses demonstrated clear increases in the number of collagen fibers and the expression of transforming growth factor–β1.

CONCLUSION The short-term results showed that treatment with low energy level CO2 fractional laser therapy could be a safe and effective option for patients with Fitzpatrick skin Types III and IV who are concerned with enlarged pores.

*Oaro Dermatology Clinic, Seoul, Korea;

Seoul Institute of Clinical Cosmetology, Seoul, Korea;

Department of Dermatology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Korea

Address correspondence and reprint requests to: Gyeong-Hun Park, MD, PhD, Department of Dermatology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, 7, Keunjaebong-gil, Hwaseong-si, Gyeonggi-do 18450, Republic of Korea, or e-mail:; or Jae Yoon Jung, MD, MS, Oaro Dermatology Clinic, 507, Nohaero, Nowongu, Seoul 01695, Republic of Korea, or e-mail:

The authors have indicated no significant interest with commercial supporters.

© 2018 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website